Persistent genital arousal disorder (PGAD) and genito-pelvic dysesthesia (GPD) are jointly known as PGAD/GPD, which is a newly discovered condition in recent years, featured by spontaneous or secondary persistent genital arousal and/or dysesthesia in the genital and pelvic areas. PGAD/GPD mainly affects women, which can seriously influence the physical and mental health of the sufferers due to the specificity of its symptoms. Most patients have anxiety, depression, and even the suicidal tendency. The medical community abroad has paid attention to PGAD/GPD, and included it in the International Classification of Diseases-11th Revision (ICD-11) . Given the fact that this newly discovered condition is under-recognized among domestic health providers at present, we summarized the current research on PGAD/GPD abroad and introduced the epidemiological characteristics, pathophysiological mechanisms, diagnosis and treatment methods of PGAD/GPD based on the review of the latest expert consensus of the International Society for the Study of Women's Sexual Health (ISSWSH) , and discussed the future research direction of PGAD/GPD and the coping strategies that should be taken by the domestic medical community, with a view to arousing medical workers' attention to the disease in China.

持续性生殖器官兴奋紊乱（PGAD）和生殖器官-骨盆感觉障碍（GPD）二者合称为持续性生殖器官兴奋紊乱/生殖器官-骨盆感觉障碍综合征（PGAD/GPD），是近年新发现的一种以自发或继发出现持续性性兴奋状态和/或生殖器官及骨盆其他区域感觉异常为特征的特殊病症。此病主要累及女性，因其症状特殊性，常对患者的身心健康造成严重影响，大多数患者处于焦虑、抑郁状态，甚至有自杀倾向。PGAD/GPD已引起国外医疗界的重视，并将其纳入国际疾病分类-11（ICD-11）。目前国内对这一新发现病症普遍认识不足。本文总结了PGAD/GPD的国外研究现状并结合国际妇女性健康研究学会（ISSWSH）最新专家共识对PGAD/GPD的流行病学特点、病理生理机制、诊断和治疗方案进行了介绍，初步探讨了PGAD/GPD的未来研究方向及国内医学界应采取的应对思路，以期引起国内广大医学工作者对此病的关注。